INTERNATIONAL PATENT: PFIZER INC. FILES APPLICATION FOR "CDK4 INHIBITORS FOR USE IN THE TREATMENT OF MANTLE CELL LYMPHOMA"

GENEVA, Oct. 4 -- PFIZER INC. (66 Hudson Boulevard EastNew York, New York 10001-2192) filed a patent application (PCT/IB2025/053148) for "CDK4 INHIBITORS FOR USE IN THE TREATMENT OF MANTLE CELL LYMPHOMA" on Mar 25, 2025. With publication no. WO/2025/202900, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ANDERS, Lars (c/o Pfizer Inc.10777 Science Center DriveSan Diego, California 92121), LI, Danan (11547 Westview ParkwaySan Diego, California 92126), ZHANG, Chonghua (10848 La Alberca AvenueSan Diego, California 92127)

Abs...